Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

EMTRIVA

EMTRICITABINE

Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview EMTRIVA is listed in Drugs@FDA under application 021896 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient EMTRICITABINE Form and strength SOLUTION; ORAL - 10MG/ML Sponsor GILEAD Submission history Latest submission status date: 2018-12-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview EMTRIVA is listed in Drugs@FDA under application 021896 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EMTRICITABINE Form and strength SOLUTION; ORAL - 10MG/ML Sponsor GILEAD Submission history Latest submission status date: 2018-12-10 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
EMTRIVA (EMTRICITABINE) | Drug Monograph | MedicHelpline